Skip to content

Side by side

Lipo-C vs Tirzepatide

Both are discussed for weight loss. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

Lipo-C and Tirzepatide compared on what BioAlmanac records.
 Lipo-CTirzepatide
What it isThe same compounded lipotropic injection under a different name, usually with L-carnitine added. The evidence position is identical: none.A once-weekly dual agonist that activates both the GIP and GLP-1 receptors, approved for type 2 diabetes and for weight management.
EvidenceHow much human evidence exists, not how well it works.PreclinicalApproved
Regulatory statusReviewed 2026-08-18Not an approved medicine. A compounded preparation, mixed by a pharmacy rather than manufactured as a reviewed product. The FDA does not review compounded preparations for safety or effectiveness before sale.Approved by the FDA as a prescription medicine for type 2 diabetes and for chronic weight management. Material sold as a research chemical is not the approved product and is not legal to sell for human use.
RoutesIntramuscularSubcutaneous
Half-lifeNot recorded120 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$0.32/mg$1.00/mg
Median per mg$0.56/mg$3.17/mg
Vendors with a price433
Storage once mixedNothing to reconstitute. Compounded preparations carry a short beyond-use date rather than a manufacturer's expiry.Refrigerated at 2–8 °C. Do not freeze. Discard if cloudy or discoloured.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.